actabiomedicaActa Biomedica ScientificaActa Biomedica Scientifica2541-94202587-9596Scientific Centre for Family Health and Human Reproduction Problems10.29413/ABS.2020-5.6.11actabiomedica-2501Research ArticleМИКРОБИОЛОГИЯ И ВИРУСОЛОГИЯMICROBIOLOGY AND VIRUSOLOGYКарбапенемазы как фактор устойчивости к антибактериальным препаратамCarbapenemases as factors of Resistance to Antibacterial DrugsНевежинаА. В.NevezhinaA. V.

младший научный сотрудник лаборатории клеточных технологий и регенеративной медицины

664003, г. Иркутск, ул. Борцов Революции, 1, Россия

Junior Research Officer at the Laboratory of Cell Technologies and Regenerative Medicine

Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation

hannanevezhina@gmail.comФГБНУ «Иркутский научный центр хирургии и травматологии»Irkutsk Scientific Centre of Surgery and Traumatology2020140120215695105Copyright © Невежина А.В., 20212021Невежина А.В.Nevezhina A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actabiomedica.ru/jour/article/view/2501антибиотикирезистентностькарбапенемыкарбапенемазыcarbapenemasebeta-lactamaseantibioticReferencesMeletis G. Carbapenem resistance: Overview of the problem and future perspectives. Ther Adv Infect Dis. 2016; 3(1): 15-21. doi: 10.1177/2049936115621709Meletis G. Carbapenem resistance: Overview of the problem and future perspectives. Ther Adv Infect Dis. 2016; 3(1): 15-21. doi: 10.1177/2049936115621709Codjoe FS, Donkor ES. Carbapenem resistance: A review. Med Sci (Basel). 2017; 6(1): 1. doi: 10.3390/medsci6010001Codjoe FS, Donkor ES. Carbapenem resistance: A review. Med Sci (Basel). 2017; 6(1): 1. doi: 10.3390/medsci6010001Dadgostar P. Antimicrobial resistance: Implications and costs. Infect Drug Resist. 2019; 12: 3903-3910. doi: 10.2147/IDR.S234610Dadgostar P. Antimicrobial resistance: Implications and costs. Infect Drug Resist. 2019; 12: 3903-3910. doi: 10.2147/IDR.S234610Walther-Rasmussen J, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother. 2006; 57(3): 373-383. doi: 10.1093/jac/dki482Walther-Rasmussen J, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother. 2006; 57(3): 373-383. doi: 10.1093/jac/dki482Hammoudi HD, Ayoub MC. The current burden of carbapenemases: Review of significant properties and dissemination among gram-negative bacteria. Antibiotics (Basel). 2020; 9(4): 186. doi: 10.3390/antibiotics9040186Hammoudi HD, Ayoub MC. The current burden of carbapenemases: Review of significant properties and dissemination among gram-negative bacteria. Antibiotics (Basel). 2020; 9(4): 186. doi: 10.3390/antibiotics9040186Mangat CS, Vadlamani G, Holicek V, et al. Molecular basis for the potent inhibition of the emerging carbapenemase VCC-1 by avibactam. Antimicrob Agents Chemother. 2019; 63(4). doi: 10.1128/aac.02112-18Mangat CS, Vadlamani G, Holicek V, et al. Molecular basis for the potent inhibition of the emerging carbapenemase VCC-1 by avibactam. Antimicrob Agents Chemother. 2019; 63(4). doi: 10.1128/aac.02112-18Roschanski N, Guenther S, Vu TTT, et al. VIM-1 carbapenemase-producing Escherichia coli isolated from retail seafood, Germany 2016 [published correction appears in Euro Surveill. 2017 Nov;22(45):]. Euro Surveill. 2017; 22(43): 17-00032. doi: 10.2807/1560-7917.ES.2017.22.43.17-00032Roschanski N, Guenther S, Vu TTT, et al. VIM-1 carbapenemase-producing Escherichia coli isolated from retail seafood, Germany 2016 [published correction appears in Euro Surveill. 2017 Nov;22(45):]. Euro Surveill. 2017; 22(43): 17-00032. doi: 10.2807/1560-7917.ES.2017.22.43.17-00032Sugawara Y, Hagiya H, Akeda Y, et al. Dissemination of carbapenemase-producing Enterobacteriaceae harbouring bla NDM or blaIMI in local market foods of Yangon, Myanmar. Sci Rep. 2019; 9: 14455. doi: 10.1038/s41598-019-51002-5Sugawara Y, Hagiya H, Akeda Y, et al. Dissemination of carbapenemase-producing Enterobacteriaceae harbouring bla NDM or blaIMI in local market foods of Yangon, Myanmar. Sci Rep. 2019; 9: 14455. doi: 10.1038/s41598-019-51002-5Elshamy AA, Aboshanab KM. A review on bacterial resistance to carbapenems: Epidemiology, detection and treatment options. Future Sci OA. 2020; 6: 3. doi: 10.2144/fsoa-2019-0098Elshamy AA, Aboshanab KM. A review on bacterial resistance to carbapenems: Epidemiology, detection and treatment options. Future Sci OA. 2020; 6: 3. doi: 10.2144/fsoa-2019-0098Полищук А.Г., Якубович Е.И., Полухина О.В., Осовских В.В., Евтушенко В.И. Карбапенемаза- продуцирующие грамотрицательные бактерии в специализированном стационаре Санкт-Петербурга. Инфекция и иммунитет. 2017; 7(2): 181-192. doi: 10.15789/2220-7619-2017-2-181-192.Polishchuk AG, Iakubovich EI, Polukhina OV, Osovskikh VV, Evtushenko VI. Carbapenemase-producing gram-negative bacteria in a specialized hospital in St. Petersburg. Russian Journal of Infection and Immunity. 2017; 7(2): 181-192. doi: 10.15789/2220-7619-2017-2-181-192. (In Russ.)Jeon JH, Lee JH, Lee JJ, et al. Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance. Int J Mol Sci. 2015; 16(5): 9654-9692. doi: 10.3390/ijms16059654Jeon JH, Lee JH, Lee JJ, et al. Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance. Int J Mol Sci. 2015; 16(5): 9654-9692. doi: 10.3390/ijms16059654Sawa T, Kooguchi K, Moriyama K. Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance. J intensive care. 2020; 8(13). doi: 10.1186/s40560-020-0429-6Sawa T, Kooguchi K, Moriyama K. Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance. J intensive care. 2020; 8(13). doi: 10.1186/s40560-020-0429-6Reyes JA, Melano R, Cardenas PA, Trueba G. Mobile genetic elements associated with carbapenemase genes in South American Enterobacterales. Braz J Infect Dis. 2020; 24(3): 231-238. doi: 10.1016/j.bjid.2020.03.002Reyes JA, Melano R, Cardenas PA, Trueba G. Mobile genetic elements associated with carbapenemase genes in South American Enterobacterales. Braz J Infect Dis. 2020; 24(3): 231-238. doi: 10.1016/j.bjid.2020.03.002Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018; 31(4): e00088-17. doi: 10.1128/CMR.00088-17Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018; 31(4): e00088-17. doi: 10.1128/CMR.00088-17Diene SM, Rolain J-M. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2014; 20(9): 831-838. doi: 10.1111/1469-0691.12655Diene SM, Rolain J-M. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2014; 20(9): 831-838. doi: 10.1111/1469-0691.12655Brouwer MSM, Tehrani KHME, Rapallini M, et al. Novel carbapenemases FLC-1 and IMI-2 encoded by an Enterobacter cloacae complex isolated from food products. Antimicrob Agents Chemother. 2019; 63(6): e02338-18. doi: 10.1128/AAC.02338-18Brouwer MSM, Tehrani KHME, Rapallini M, et al. Novel carbapenemases FLC-1 and IMI-2 encoded by an Enterobacter cloacae complex isolated from food products. Antimicrob Agents Chemother. 2019; 63(6): e02338-18. doi: 10.1128/AAC.02338-18Aires-de-Sousa M, Ortiz de la Rosa J, Gonçalves M, Pereira A, Nordmann P, Poirel L. Epidemiology of carbapenemaseproducing Klebsiella pneumoniae in a hospital, Portugal. Emerg Infect Dis. 2019; 25(9): 1632-1638. doi: 10.3201/eid2509.190656Aires-de-Sousa M, Ortiz de la Rosa J, Gonçalves M, Pereira A, Nordmann P, Poirel L. Epidemiology of carbapenemaseproducing Klebsiella pneumoniae in a hospital, Portugal. Emerg Infect Dis. 2019; 25(9): 1632-1638. doi: 10.3201/eid2509.190656Piccirilli A, Mercuri PS, Galleni M, et al. P174E substitution in GES-1 and GES-5 β-lactamases improves catalytic efficiency toward carbapenems. Antimicrob Agents Chemother. 2018; 62(5): e01851-17. doi: 10.1128/AAC.01851-17Piccirilli A, Mercuri PS, Galleni M, et al. P174E substitution in GES-1 and GES-5 β-lactamases improves catalytic efficiency toward carbapenems. Antimicrob Agents Chemother. 2018; 62(5): e01851-17. doi: 10.1128/AAC.01851-17Chihi H, Bonnin RA, Bourouis A, Mahrouki S, Besbes S, Moussa MB, et al. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa. J Glob Antimicrob Resist. 2016; 5: 47-50. doi: 10.1016/j.jgar.2016.03.005Chihi H, Bonnin RA, Bourouis A, Mahrouki S, Besbes S, Moussa MB, et al. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa. J Glob Antimicrob Resist. 2016; 5: 47-50. doi: 10.1016/j.jgar.2016.03.005Hopkins KL, Findlay J, Meunier D, Cummins M, Curtis S, Kustos I, et al. Serratia marcescens producing SME carbapenemases: An emerging resistance problem in the UK? J Antimicrob Chemother. 2017; 72(5): 1535-1537. doi: 10.1093/jac/dkw567Hopkins KL, Findlay J, Meunier D, Cummins M, Curtis S, Kustos I, et al. Serratia marcescens producing SME carbapenemases: An emerging resistance problem in the UK? J Antimicrob Chemother. 2017; 72(5): 1535-1537. doi: 10.1093/jac/dkw567Iovene MR, Pota V, Galdiero M, et al. First Italian outbreak of VIM-producing Serratia marcescens in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review. World J Clin Cases. 2019; 7(21): 3535-3548. doi: 10.12998/wjcc.v7.i21.3535Iovene MR, Pota V, Galdiero M, et al. First Italian outbreak of VIM-producing Serratia marcescens in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review. World J Clin Cases. 2019; 7(21): 3535-3548. doi: 10.12998/wjcc.v7.i21.3535Sahuquillo-Arce JM, Hernandez-Cabezas A, Yarad-Auad F, Ibanez-Martínez E, Falomir-Salcedo P, Ruiz-Gaitán A. Carbapenemases: A worldwide threat to antimicrobial therapy. World J Pharmacol. 2015; 4(1): 75-95. doi: 10.5497/wjp.v4.i1.75Sahuquillo-Arce JM, Hernandez-Cabezas A, Yarad-Auad F, Ibanez-Martínez E, Falomir-Salcedo P, Ruiz-Gaitán A. Carbapenemases: A worldwide threat to antimicrobial therapy. World J Pharmacol. 2015; 4(1): 75-95. doi: 10.5497/wjp.v4.i1.75Liakopoulos A, Mevius D, Ceccarelli D. A review of SHV extended-spectrum β-lactamases: Neglected yet ubiquitous. Front Microbiol. 2016; 7: 1374. doi: 10.3389/fmicb.2016.01374Liakopoulos A, Mevius D, Ceccarelli D. A review of SHV extended-spectrum β-lactamases: Neglected yet ubiquitous. Front Microbiol. 2016; 7: 1374. doi: 10.3389/fmicb.2016.01374Naas T, Dortet L, Iorga BI. Structural and functional aspects of class A carbapenemases. Current Drug Targets. 2016; 17(9): 1006-1028. doi: 10.2174/1389450117666160310144501Naas T, Dortet L, Iorga BI. Structural and functional aspects of class A carbapenemases. Current Drug Targets. 2016; 17(9): 1006-1028. doi: 10.2174/1389450117666160310144501Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: Detection and antimicrobial therapy. Front Microbiol. 2019; 10: 1823. doi: 10.3389/fmicb.2019.01823Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: Detection and antimicrobial therapy. Front Microbiol. 2019; 10: 1823. doi: 10.3389/fmicb.2019.01823Niu S, Chavda KD, Wei J, et al. A ceftazidime- avibactamresistant and carbapenem-susceptible Klebsiella pneumoniae strain harboring blaKPC-14 isolated in New York City. mSphere. 2020; 5(4): e00775-20. doi: 10.1128/mSphere.00775-20Niu S, Chavda KD, Wei J, et al. A ceftazidime-avibactamresistant and carbapenem-susceptible Klebsiella pneumoniae strain harboring blaKPC-14 isolated in New York City. mSphere. 2020; 5(4): e00775-20. doi: 10.1128/mSphere.00775-20Bonnin RA, Jousset AB, Urvoy N, Gauthier L, Tlili L,Bonnin RA, Jousset AB, Urvoy N, Gauthier L, Tlili L, Creton E, et al. Detection of GES-5 carbapenemase in Klebsiella pneumoniae, a newcomer in France. Antimicrob Agents Chemother. 2017; 61(3): e02263-16. doi: 10.1128/AAC.02263-16Creton E, et al. Detection of GES-5 carbapenemase in Klebsiella pneumoniae, a newcomer in France. Antimicrob Agents Chemother. 2017; 61(3): e02263-16. doi: 10.1128/AAC.02263-16Marsh JW, Mustapha MM, Griffith MP, Evans DR, Ezeonwuka C, Pasculle AW, et al. Evolution of outbreak-causing carbapenem-resistant Klebsiella pneumoniae ST258 at a tertiary care hospital over 8 years. MBio. 2019; 10(5): e01945-19. doi: 10.1128/mBio.01945-19Marsh JW, Mustapha MM, Griffith MP, Evans DR, Ezeonwuka C, Pasculle AW, et al. Evolution of outbreak- causing carbapenem-resistant Klebsiella pneumoniae ST258 at a tertiary care hospital over 8 years. MBio. 2019; 10(5): e01945-19. doi: 10.1128/mBio.01945-19Duin D van, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017; 8(4): 460-469. doi: 10.1080/21505594.2016.1222343Duin D van, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017; 8(4): 460-469. doi: 10.1080/21505594.2016.1222343Antonelli A, D’Andrea MM, Di Pilato V, et al. Characterization of a novel putative Xer-dependent integrative mobile element carrying the bla(NMC-A) carbapenemase gene, inserted into the chromosome of members of the Enterobacter cloacae complex. Antimicrob Agents Chemother. 2015; 59(10): 6620-6624. doi: 10.1128/aac.01452-15Antonelli A, D›Andrea MM, Di Pilato V, et al. Characterization of a novel putative Xer-dependent integrative mobile element carrying the bla(NMC-A) carbapenemase gene, inserted into the chromosome of members of the Enterobacter cloacae complex. Antimicrob Agents Chemother. 2015; 59(10): 6620-6624. doi: 10.1128/aac.01452-15Boyd DA, Mataseje LF, Davidson R, Delport JA, Fuller J, Hoang L, et al. Enterobacter cloacae complex isolates harboring bla NMC-A or blaIMI-type class A carbapenemase genes on novel chromosomal integrative elements and plasmids. Antimicrob Agents Chemother. 2017; 61(5): e02578-16. doi: 10.1128/AAC.02578-16Boyd DA, Mataseje LF, Davidson R, Delport JA, Fuller J, Hoang L, et al. Enterobacter cloacae complex isolates harboring bla NMC-A or blaIMI-type class A carbapenemase genes on novel chromosomal integrative elements and plasmids. Antimicrob Agents Chemother. 2017; 61(5): e02578-16. doi: 10.1128/AAC.02578-16Hopkins KL, Findlay J, Doumith M, Mather B, Meunier D, D’Arcy S, et al. IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK. J Antimicrob Chemother. 2017; 72(7): 2129-2131. doi: 10.1093/jac/dkx103Hopkins KL, Findlay J, Doumith M, Mather B, Meunier D, D’Arcy S, et al. IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK. J Antimicrob Chemother. 2017; 72(7): 2129-2131. doi: 10.1093/jac/dkx103Huang L, Wang X, Feng Y, Xie Y, Xie L, Zong Z. First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China. Ann Clin Microbiol Antimicrob. 2015; 14: 51. doi: 10.1186/s12941-015-0112-2Huang L, Wang X, Feng Y, Xie Y, Xie L, Zong Z. First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China. Ann Clin Microbiol Antimicrob. 2015; 14: 51. doi: 10.1186/s12941-015-0112-2Fonseca F, Sarmento AC, Henriques I, Samyn B, Beeumen J van, Domingues P, et al. Biochemical characterization of SFC-1, a class A carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2007; 51(12): 4512-4514. doi: 10.1128/AAC.00491-07Fonseca F, Sarmento AC, Henriques I, Samyn B, Beeumen J van, Domingues P, et al. Biochemical characterization of SFC-1, a class A carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2007; 51(12): 4512-4514. doi: 10.1128/AAC.00491-07Henriques I, Moura A, Alves A, Saavedra MJ, Correia A. Molecular characterization of a carbapenem-hydrolyzing class A β-lactamase, SFC-1, from Serratia fonticola UTAD54. Antimicrob Agents Chemother. 2004; 48(6): 2321-2324; doi: 10.1128/AAC.48.6.2321-2324.2004Henriques I, Moura A, Alves A, Saavedra MJ, Correia A. Molecular characterization of a carbapenem-hydrolyzing class A β-lactamase, SFC-1, from Serratia fonticola UTAD54. Antimicrob Agents Chemother. 2004; 48(6): 2321-2324; doi: 10.1128/AAC.48.6.2321-2324.2004Becka SA, Zeiser ET, Marshall SH, et al. Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans. Diagn Microbiol Infect Dis. 2018; 92(3): 253-258. doi: 10.1016/j.diagmicrobio.2018.06.005Becka SA, Zeiser ET, Marshall SH, et al. Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans. Diagn Microbiol Infect Dis. 2018; 92(3): 253-258. doi: 10.1016/j.diagmicrobio.2018.06.005Juan C, Torrens G, Gonzalez-Nicolau M, Oliver A. Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens. FEMS Microbiol Rev. 2017; 41(6): 781-815. doi: 10.1093/femsre/fux043Juan C, Torrens G, Gonzalez-Nicolau M, Oliver A. Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens. FEMS Microbiol Rev. 2017; 41(6): 781-815. doi: 10.1093/femsre/fux043Papp-Wallace KM., Scott AB, Zeiser ET, et al. Overcoming an extremely drug resistant (XDR) pathogen: Avibactam restores susceptibility to ceftazidime for Burkholderia cepacia complex isolates from cystic fibrosis patients. ACS Infect Dis. 2017; 3(7): 502-511. doi: 10.1021/acsinfecdis.7b00020Papp-Wallace KM., Scott AB, Zeiser ET, et al. Overcoming an extremely drug resistant (XDR) pathogen: Avibactam restores susceptibility to ceftazidime for Burkholderia cepacia complex isolates from cystic fibrosis patients. ACS Infect Dis. 2017; 3(7): 502-511. doi: 10.1021/acsinfecdis.7b00020Nicoletti AG, Marcondes MFM, Martins WMBS, Almeida LGP, Nicolás MF, Vasconcelos ATR, et al. Characterization of BKC-1 class A carbapenemase from Klebsiella pneumoniae clinical isolates in Brazil. Antimicrob Agents Chemother. 2015; 59(9): 5159-5164. doi: 10.1128/AAC.00158-15Nicoletti AG, Marcondes MFM, Martins WMBS, Almeida LGP, Nicolás MF, Vasconcelos ATR, et al. Characterization of BKC-1 class A carbapenemase from Klebsiella pneumoniae clinical isolates in Brazil. Antimicrob Agents Chemother. 2015; 59(9): 5159-5164.Dortet L, Poirel L, Abbas S, Oueslati S, Nordmann P. Genetic and biochemical characterization of FRI-1, a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae. Antimicrob Agents Chemother. 2015; 59(12): 7420-7425. doi: 10.1128/AAC.01636-15doi: 10.1128/AAC.00158-15Schauer J, Gatermann SG, Hoffmann D, Hupfeld L, Pfennigwerth N. GPC-1, a novel class A carbapenemase detected in a clinical Pseudomonas aeruginosa isolate. J Antimicrob Chemother. 2020; 75(4): 911-916. doi: 10.1093/jac/dkz536Dortet L, Poirel L, Abbas S, Oueslati S, Nordmann P. Genetic and biochemical characterization of FRI-1, a carbapenemhydrolyzing class A β-lactamase from Enterobacter cloacae. Antimicrob Agents Chemother. 2015; 59(12): 7420-7425. doi: 10.1128/AAC.01636-15Lv R, Guo J, Yan Y, et al. Characterization of a novel class A carbapenemase PAD-1 from Paramesorhizobium desertii A-3-ET, a strain highly resistant to β-lactam antibiotics. Sci Rep. 2017; 7: 8370. doi: 10.1038/s41598-017-07841-1Schauer J, Gatermann SG, Hoffmann D, Hupfeld L, Pfennigwerth N. GPC-1, a novel class A carbapenemase detected in a clinical Pseudomonas aeruginosa isolate. J Antimicrob Chemother. 2020; 75(4): 911-916. doi: 10.1093/jac/dkz536Tamma PD, Simner PJ. Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol. 2018; 56(11): e01140-18. doi: 10.1128/JCM.01140-18Lv R, Guo J, Yan Y, et al. Characterization of a novel class A carbapenemase PAD-1 from Paramesorhizobium desertii A-3-ET, a strain highly resistant to β-lactam antibiotics. Sci Rep. 2017; 7: 8370. doi: 10.1038/s41598-017-07841-1Mojica MF, Bonomo RA, Fast W. B1-metallo-β-lactamases: Where do we stand? Curr Drug Targets. 2016; 17(9): 1029-1050. doi: 10.2174/1389450116666151001105622Tamma PD, Simner PJ. Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol. 2018; 56(11): e01140-18. doi: 10.1128/JCM.01140-18Mercuri PS, Bouillenne F, Boschi L, et al. Biochemical characterization of the FEZ-1 metallo-beta-lactamase of Legionella gormanii ATCC 33297T produced in Escherichia coli. Antimicrob Agents Chemother. 2001; 45(4): 1254-1262. doi: 10.1128/AAC.45.4.1254-1262.2001Mojica MF, Bonomo RA, Fast W. B1-metallo-β-lactamases: Where do we stand? Curr Drug Targets. 2016; 17(9): 1029-1050. doi: 10.2174/1389450116666151001105622Lowe CF, Matic N, Champagne S, Romney MG, Leung V, Ritchie G. The brief case: IMP, the uncommonly common carbapenemase. J Clin Microbiol. 2020; 58(4): e01094-19. doi: 10.1128/JCM.01094-19Mercuri PS, Bouillenne F, Boschi L, et al. Biochemical characterization of the FEZ-1 metallo-beta-lactamase of Legionella gormanii ATCC 33297T produced in Escherichia coli. Antimicrob Agents Chemother. 2001; 45(4): 1254-1262. doi: 10.1128/AAC.45.4.1254-1262.2001Bonardi S, Pitino R. Carbapenemase-producing bacteria in food-producing animals, wildlife and environment: A challenge for human health. Ital J Food Saf. 2019; 8(2): 7956. doi: 10.4081/ijfs.2019.7956Lowe CF, Matic N, Champagne S, Romney MG, Leung V, Ritchie G. The brief case: IMP, the uncommonly common carbapenemase. J Clin Microbiol. 2020; 58(4): e01094-19. doi: 10.1128/JCM.01094-19Makena A, Duzgun AO, Brem J, McDonough MA, Rydzik AM, Abboud MI, et al. Comparison of Verona integron-Borne metallo-β-lactamase (VIM) variants reveals differences in stability and inhibition profiles. Antimicrob Agents Chemother. 2016; 60(3): 1377-1384. doi: 10.1128/AAC.01768-15Bonardi S, Pitino R. Carbapenemase-producing bacteria in food-producing animals, wildlife and environment: A challenge for human health. Ital J Food Saf. 2019; 8(2): 7956. doi: 10.4081/ijfs.2019.7956Zmarlicka M, Nailor M, Nicolau D. Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics. Infect Drug Resist. 2015; 8: 297-309. doi: 10.2147/IDR.S39186Makena A, Duzgun AO, Brem J, McDonough MA, Rydzik AM, Abboud MI, et al. Comparison of Verona integron-Borne metallo-β-lactamase (VIM) variants reveals differences in stability and inhibition profiles. Antimicrob Agents Chemother. 2016; 60(3): 1377-1384. doi: 10.1128/AAC.01768-15Bahr G, Vitor-Horen L, Bethel ChR, Bonomo RA, Gonzalez LJ, Vila AJ. Clinical evolution of New Delhi metallo-β-lactamase (NDM) optimizes resistance under Zn(II) deprivation. Antimicrob Agents Chemother. 2017; 62(1): e01849-17. doi: 10.1128/AAC.01849-17Zmarlicka M, Nailor M, Nicolau D. Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics. Infect Drug Resist. 2015; 8: 297-309. doi: 10.2147/IDR.S39186Weber RE, Pietsch M, Frühauf A, Pfeifer Y, Martin M, Luft D, et al. IS26-mediated transfer of blaNDM-1 as the main route of resistance transmission during a polyclonal, multispecies outbreak in a German hospital. Front Microbiol. 2019; 10: 2817. doi: 10.3389/fmicb.2019.02817Bahr G, Vitor-Horen L, Bethel ChR, Bonomo RA, Gonzalez LJ, Vila AJ. Clinical evolution of New Delhi metallo-β-lactamase (NDM) optimizes resistance under Zn(II) deprivation. Antimicrob Agents Chemother. 2017; 62(1): e01849-17. doi: 10.1128/AAC.01849-17Adams MD, Pasteran F, Traglia GM, Martinez J, Huang F, Liu C, et al. Distinct mechanisms of dissemination of NDM-1 metallo-β-lactamase in Acinetobacter species in Argentina. Antimicrob Agents Chemother. 2020; 64(5): e00324-20. doi: 10.1128/AAC.00324-20Weber RE, Pietsch M, Frühauf A, Pfeifer Y, Martin M, Luft D, et al. IS26-mediated transfer of blaNDM-1 as the main route of resistance transmission during a polyclonal, multispecies outbreak in a German hospital. Front Microbiol. 2019; 10: 2817. doi: 10.3389/fmicb.2019.02817Wendel AF, MacKenzie CR. Characterization of a novel metallo-β-lactamase variant, GIM-2, from a clinical isolate of Enterobacter cloacae in Germany. Antimicrob Agents Chemother. 2015; 59(3): 1824-1825. doi: 10.1128/AAC.05062-14Adams MD, Pasteran F, Traglia GM, Martinez J, Huang F, Liu C, et al. Distinct mechanisms of dissemination of NDM-1 metallo-β-lactamase in Acinetobacter species in Argentina. Antimicrob Agents Chemother. 2020; 64(5): e00324-20. doi: 10.1128/AAC.00324-20Lu Y, Zhao S, Liang H, Zhang W, Liu J, Hu H. The first report of a novel IncHI1B blaSIM-1-carrying megaplasmid pSIM-1-BJ01 from a clinical Klebsiella pneumoniae isolate. Infect Drug Resist. 2019; 12: 2103-2112. doi: 10.2147/IDR.S212333Wendel AF, MacKenzie CR. Characterization of a novel metallo-β-lactamase variant, GIM-2, from a clinical isolate of Enterobacter cloacae in Germany. Antimicrob Agents Chemother. 2015; 59(3): 1824-1825. doi: 10.1128/AAC.05062-14Zheng Z, Cheng Q, Chan EW‐C, Chen S. Genetic and biochemical characterization of VMB‐1, a novel metallo‐β‐lactamase encoded by a conjugative, broad‐host range IncC plasmid from Vibrio spp. Adv. Biosys. 2020; 4: 1900221. doi: 10.1002/adbi.201900221Lu Y, Zhao S, Liang H, Zhang W, Liu J, Hu H. The first report of a novel IncHI1B blaSIM-1-carrying megaplasmid pSIM-1-BJ01 from a clinical Klebsiella pneumoniae isolate. Infect Drug Resist. 2019; 12: 2103-2112. doi: 10.2147/IDR.S212333Poirel L, Palmieri M, Brilhante M, Masseron A, Perreten V, Nordmann P. PFM-like enzymes are a novel family of subclass B2 metallo-β-lactamases fromPseudomonas synxanthabelonging to the Pseudomonas fluorescens complex Nordmann. Antimicrob Agents Chemother. 2020; 64(2): e01700-19. doi: 10.1128/AAC.01700-19Zheng Z, Cheng Q, Chan EW‐C, Chen S. Genetic and biochemical characterization of VMB‐1, a novel metallo‐β‐ lactamase encoded by a conjugative, broad‐host range IncC plasmid from Vibrio spp. Adv. Biosys. 2020; 4: 1900221. doi: 10.1002/adbi.201900221Brem J, Struwe WB, Rydzik AM, et al. Studying the activesite loop movement of the São Paolo metallo-β-lactamase-1. Chem Sci. 2015; 6(2): 956-963. doi: 10.1039/c4sc01752hPoirel L, Palmieri M, Brilhante M, Masseron A, Perreten V, Nordmann P. PFM-like enzymes are a novel family of subclass B2 metallo-β-lactamases from Pseudomonas synxantha belonging to the Pseudomonas fluorescens complex Nordmann. Antimicrob Agents Chemother. 2020; 64(2): e01700-19. doi: 10.1128/AAC.01700-19Lopez C, Ayala JA, Bonomo RA, et al. Protein determinants of dissemination and host specificity of metallo-β-lactamases. Nat Commun. 2019; 10: 3617. doi: 10.1038/s41467-019-11615-wBrem J, Struwe WB, Rydzik AM, et al. Studying the activesite loop movement of the São Paolo metallo-β- lactamase-1. Chem Sci. 2015; 6(2): 956-963. doi: 10.1039/c4sc01752hJabalameli F, Taki E, Emaneini M, Beigverdi R. Prevalence of metallo-β-lactamase-encoding genes among carbapenemresistant Pseudomonas aeruginosa strains isolated from burn patients in Iran. Rev Soc Bras Med Trop. 2018; 51(3): 270-276. doi: 10.1590/0037-8682-0044-2018Lopez C, Ayala JA, Bonomo RA, et al. Protein determinants of dissemination and host specificity of metallo-β-lactamases. Nat Commun. 2019; 10: 3617. doi: 10.1038/s41467-019-11615-wSmith CA, Stewart NK, Toth M, Vakulenko SB. Structural insights into the mechanism of carbapenemase activity of the OXA-48 β-lactamase. Antimicrob Agents Chemother. 2019; 63(10): e01202-19. doi: 10.1128/AAC.01202-19Jabalameli F, Taki E, Emaneini M, Beigverdi R. Prevalence of metallo-β-lactamase-encoding genes among carbapenemresistant Pseudomonas aeruginosa strains isolated from burn patients in Iran. Rev Soc Bras Med Trop. 2018; 51(3): 270-276. doi: 10.1590/0037-8682-0044-2018Pasteran F, Denorme L, Ote I, et al. Rapid identification of OXA-48 and OXA-163 subfamilies in carbapenem-resistant gram-negative Bacilli with a novel immunochromatographic lateral flow assay. J Clin Microbiol. 2016; 54(11): 2832-2836. doi: 10.1128/JCM.01175-16Smith CA, Stewart NK, Toth M, Vakulenko SB. Structural insights into the mechanism of carbapenemase activity of the OXA-48 β-lactamase. Antimicrob Agents Chemother. 2019; 63(10): e01202-19. doi: 10.1128/AAC.01202-19Doi Y. Treatment options for carbapenem-resistant gramnegative bacterial infections. Clin Infect Dis. 2019; 69(7): S565-S575. doi: 10.1093/cid/ciz830Pasteran F, Denorme L, Ote I, et al. Rapid identification of OXA-48 and OXA-163 subfamilies in carbapenem-resistant gram-negative Bacilli with a novel immunochromatographic lateral flow assay. J Clin Microbiol. 2016; 54(11): 2832-2836. doi: 10.1128/JCM.01175-16Joshi PR, Acharya M, Kakshapati T, et al. Co-existence of bla OXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: Antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control. 2017; 6(21). doi: 10.1186/s13756-017-0180-5Doi Y. Treatment options for carbapenem-resistant gramnegative bacterial infections. Clin Infect Dis. 2019; 69(7): S565-S575. doi: 10.1093/cid/ciz830Kuzmenkov AYu, Trushin IV, Avramenko AA, Eidelshtein MV, Dekhnich AV, Kozlov RS. Amrmap: online platform for monitoring antibiotic resistance. КМАХ. 2017. 19(2): 84-90. (In Russ.)Joshi PR, Acharya M, Kakshapati T, et al. Co-existence of bla OXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: Antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control. 2017; 6(21). doi: 10.1186/s13756-017-0180-5Baeza LL, Pfennigwerth N, Greissl C, Gottig S, Saleh A, Stelzer Y, et al. Comparison of five methods for detection of carbapenemases in Enterobacterales with proposal of a new algorithm. Clin Microbiol Infect. 2019; 25(10): 1286.e9-1286.e15. doi: 10.1016/j.cmi.2019.03.003Кузьменков А.Ю., Трушин И.В., Авраменко А.А., Эйдельштейн М.В., Дехнич А.В., Козлов Р.С. Amrmap: интернетплатформа мониторинга антибиотикорезистентности. КМАХ. 2017. 19(2): 84-90.Zhivich A. Fighting bacterial resistance: Approaches, challenges, and opportunities in the search for new antibiotics. Part 1. Antibiotics used in clinical practice: mechanisms of action and the development of bacterial resistance. The Microbiology Independent Research (MIR) journal. 2017; 4(1): 31-51. doi: 10.18527/2500-2236-2017-4-1-31-51Baeza LL, Pfennigwerth N, Greissl C, Gottig S, Saleh A, Stelzer Y, et al. Comparison of five methods for detection of carbapenemases in Enterobacterales with proposal of a new algorithm. Clin Microbiol Infect. 2019; 25(10): 1286.e9-1286.e15. doi: 10.1016/j.cmi.2019.03.003Lohans CT, Groesen E van, Kumar K, Tooke CL, Spencer J, Paton RS, et al. A new mechanism for β‐ lactamases: Class D enzymes degrade 1β‐methyl carbapenems through lactone formation. Angew Chem Int Ed Engl. 2018; 57: 1282. doi: 10.1002/anie.201711308Zhivich A. Fighting bacterial resistance: Approaches, challenges, and opportunities in the search for new antibiotics. Part 1. Antibiotics used in clinical practice: mechanisms of action and the development of bacterial resistance. The Microbiology Independent Research (MIR) journal. 2017; 4(1): 31-51. doi: 10.18527/2500-2236-2017-4-1-31-51Shurygina IA, Prozorova GF, Trukhan IS, Korzhova SA, Fadeeva TV, Pozdnyakov AS, et al. NonToxic Silver/Poly-1-Vinyl-1,2,4-Triazole. Nanomaterials. 2020; 10(8): 1477. doi: 10.3390/nano10081477/Lohans CT, Groesen E van, Kumar K, Tooke CL, Spencer J, Paton RS, et al. A new mechanism for β‐ lactamases: Class D enzymes degrade 1β‐methyl carbapenems through lactone formation. Angew Chem Int Ed Engl. 2018; 57: 1282. doi: 10.1002/anie.201711308Williamson DA, Carter GP, Howden BP. Current and emerging topical antibacterials and antiseptics: Agents, action, and resistance patterns. Clin Microbiol Rev. 2017; 30(3): 827-860. doi: 10.1128/CMR.00112-16Shurygina IA, Prozorova GF, Trukhan IS, Korzhova SA, Fadeeva TV, Pozdnyakov AS, et al. NonToxic Silver/Poly-1-Vinyl-1,2,4-Triazole. Nanomaterials. 2020; 10(8): 1477. doi: 10.3390/nano10081477/Belete TM. Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents. Hum Microb J. 2019; 11: 100052. doi: 10.1016/j.humic.2019.01.001Williamson DA, Carter GP, Howden BP. Current and emerging topical antibacterials and antiseptics: Agents, action, and resistance patterns. Clin Microbiol Rev. 2017; 30(3): 827-860. doi: 10.1128/CMR.00112-16Beloborodov VB, Gusarov VG, Dekhnich AV, Zamiatin MN, Zubareva NA, Zyrianov SK, et al. Diagnostics and antimicrobial therapy of infections caused by multidrug-resistant microorganisms: Guidelines of the Russian non-profit public organization «Association of Anesthesiologists and Resuscitators», Interregional Public Organization «Alliance of Clinical Chemotherapists and Microbiologists», Interregional Association for Clinical Microbiology and Antimicrobial Organization (МАКМАХ) Sepsis Forum». Messenger of Anesthesiology and Resuscitaion. 2020; 17(1): 52-83. (In Russ.)Belete TM. Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents. Hum Microb J. 2019; 11: 100052. doi: 10.1016/j.humic.2019.01.001Lazareva IV, Ageevets VA, Ershova TA, Zueva LP, Goncharov AE, Daryina MG, et al. Distribution and antibacterial resistance of gram-negative bacteria, producers of carbapenemases, in St. Petersburg and some other regions of the Russian Federation. Antibiotics and Chemotherapy. 2016; 61(11-12): 28-38. (In Russ.)Белобородов В.Б., Гусаров В.Г., Дехнич А.В., Замятин М.Н., Зубарева Н.А., Зырянов С.К. и др. Диагностика и антимикробная терапия инфекций, вызванных полирезистентными микроорганизмами: методические рекомендации Российской некоммерческой общественной организации «Ассоциация анестезиологов-реаниматологов», Межрегиональной общественной организации «Альянс клинических химиотерапевтов и микробиологов», Межрегиональной ассоциации по клинической микробиологии и антимикробной химиотерапии (МАКМАХ), Общественной организации «Российский Сепсис Форум». Вестник анестезиологии и реаниматологии. 2020; 17 (1): 52-83.Pagano M, Martins AF, Barth AL. Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii. Braz J Microbiol. 2016; 47(4): 785-792. doi: 10.1016/j.bjm.2016.06.005Лазарева И.В., Агеевец В.А., Ершова Т.А., Зуева Л.П., Гончаров А.Е., Дарьина М.Г. и др. Распространение и антибактериальная резистентность грамотрицательных бактерий, продуцентов карбапенемаз, в Санкт-Петербурге и некоторых других регионах Российской Федерации. Антибиотики и химиотерапия. 2016; 61 (11-12): 28-38.Shek EA, Sukhorukova MV, Edelstein MV, Skleenova EYu, Ivanchik NV, Shajdullina ER, et al. Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: Results of multicenter epidemiological study “MARATHON 2015–2016”. Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2): 160-170. doi: 10.36488/cmac.2019.2.160-170Pagano M, Martins AF, Barth AL. Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii. Braz J Microbiol. 2016; 47(4): 785-792. doi: 10.1016/j.bjm.2016.06.005Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-producing organisms: A global scourge. Clin Infect Dis. 2018; 66(8): 1290-1297. doi: 10.1093/cid/cix893Shek EA, Sukhorukova MV, Edelstein MV, Skleenova EYu, Ivanchik NV, Shajdullina ER, et al. Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: Results of multicenter epidemiological study “MARATHON 2015–2016”. Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2): 160-170. doi: 10.36488/cmac.2019.2.160-170Shek EA, Sukhorukova MV, Edelstein MV, Skleenova EYu, Ivanchik NV, Shajdullina ER, et al. Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: Results of multicenter epidemiological study “MARATHON 2015–2016”. Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2): 160-170. doi: 10.36488/cmac.2019.2.160-170Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-producing organisms: A global scourge. Clin Infect Dis. 2018; 66(8): 1290-1297. doi: 10.1093/cid/cix893Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-producing organisms: A global scourge. Clin Infect Dis. 2018; 66(8): 1290-1297. doi: 10.1093/cid/cix893

The authors declare that there are no conflicts of interest present.